Individuals on steroids for persistent disease may be more at threat of COVID-19

Individuals taking a type of corticosteroid may be more likely to contract the virus that is causing COVID-19 and may have worse signs if they do.

Share on Pinterest

An editorial of The Journal of Scientific Endocrinology & Metabolic Process( JCEM) has recommended that people who take the class of steroid hormonal agents referred to as glucocorticoids might be most likely to contract COVID-19 and, if they do, are more likely to have serious symptoms. Glucocorticoids are often a medication medical professionals recommend for persistent inflammatory illness, such as asthma, persistent obstructive pulmonary illness, and inflammatory bowel illness.

As the unique SARS-CoV-2 virus quickly spreads out throughout the world, research continues apace to assist understand how the virus spreads and what effects it has on individuals who then develop the illness COVID-19

Making use of this emergent research, the editors of the JCEM highlight the possible relationship in between the corticosteroids glucocorticoids and COVID-19

Medical professionals widely prescribe glucocorticoids for different chronic inflammatory diseases, and they can be extremely reliable in the treatment of these health problems. The factor for this is that they considerably reduce inflammation. A more association with this, nevertheless, is their suppression of an individual’s immune system.

According to the editors of the JCEM, this implies individuals who routinely take glucocorticoids may be more likely to experience an infection with the SARS-CoV-2 infection since their immune systems are likely to be less reliable at battling it off.

This might also mean that an individual taking glucocorticoids will experience a more severe case of COVID-19 from infection with the infection.

The World Health Organisation (WHO) presently advise against using glucocorticoids to deal with COVID-19

Nevertheless, according to the JCEM editors, clinicians shou